Article thumbnail

Research progress of cerebral hyperperfusion syndrome

By Guang ZHANG, Shi-yi ZHU, Zhi-yong JI, Pei-quan ZHOU, Shan-cai XU and Huai-zhang SHI

Abstract

Cerebral hyperperfusion syndrome (CHS) is a rare syndrome deriving from carotid endovascular treatment with a high mortality. CHS can be derived by carotid endarterectomy (CEA), carotid artery stenting (CAS) and intracranial artery stenting. This review aims to summarize the progress of clinical manifestations, risk factors, pathogenesis, diagnostic criteria, prevention and treatment for CHS in recent years. DOI: 10.3969/j.issn.1672-6731.2017.12.00

Topics: Hemoperfusion, Brain, Angioplasty, Stents, Postoperative complications, Review, Neurology. Diseases of the nervous system, RC346-429
Publisher: Tianjin Huanhu Hospital
Year: 2017
DOI identifier: 10.3969/j.issn.1672-6731.2017.12.003
OAI identifier: oai:doaj.org/article:ab0a1b91fe7f4a34ad2833b5b433dc78
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1672-6731 (external link)
  • http://www.cjcnn.org/index.php... (external link)
  • https://doaj.org/article/ab0a1... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.